Anterix (ATEX) EBT Margin (2013 - 2026)

Anterix's EBT Margin history runs 14 years deep, the most recent figure standing at 1040.96% for Q1 2026.

• Quarterly EBT Margin rose 32951.0% year-over-year to 1040.96% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1472.17% (up 162936.0% YoY) and the FY2026 annual result came in at 1472.17%, up 162936.0% from the prior year.
• EBT Margin was 1040.96% for Q1 2026 at Anterix, up from 550.1% in the prior quarter.
• Across five years, EBT Margin topped out at 3933.89% in Q3 2025 and bottomed at 3879.4% in Q2 2022.
• A 5-year average of 215.79% and a median of 387.83% in 2023 frame the typical range for EBT Margin.
• Annual changes were most pronounced in 2023 — EBT Margin jumped 586818 bps — and 2024, when it plunged 341824 bps.
• Anterix's EBT Margin stood at 1351.21% in 2022, then surged by 110 bps to 131.08% in 2023, then jumped by 264 bps to 477.39% in 2024, then sank by 215 bps to 550.1% in 2025, then soared by 289 bps to 1040.96% in 2026.
• Business Quant data shows ATEX's EBT Margin at 1040.96% in Q1 2026, 550.1% in Q4 2025, and 3933.89% in Q3 2025.